Kroger (KR) Q2 2025 earnings review
Momentum Builds: Kroger Lifts Guidance as Sales Accelerate and Cost Controls Shine
Kroger delivered a strong second quarter, with identical sales (ex-fuel) accelerating for the sixth consecutive quarter to 3.4%, beating expectations. The growth was driven by strong execution in Pharmacy, Fresh, and a 16% surge in eCommerce sales. Importantly, impressive cost discipline led to a 41 basis point improvement in the underlying operating expense rate, funding price investments while still boosting profitability. This operational momentum gave management the confidence to raise full-year guidance for identical sales, operating profit, and EPS, signaling a positive outlook despite a cautious consumer environment.
🐂 Bull Case
Identical sales growth has consistently improved for six straight quarters, reaching 3.4% in Q2. This demonstrates strong execution and resonance with customers in key categories like Fresh and Pharmacy.
The company achieved a significant 41 basis point improvement in its underlying OG&A rate. This discipline is funding price investments to drive volume while also improving profitability, creating a virtuous cycle.
Management's confidence is clear as they raised full-year guidance for identical sales (to 2.7%-3.4%), operating profit, and adjusted EPS, indicating the strong first-half performance is sustainable.
🐻 Bear Case
Management explicitly noted that year-over-year comparisons become more difficult in the second half of the year. Guidance for Q3 ID sales implies a slight sequential deceleration from Q2's strong pace.
The rapid growth in the lower-margin Pharmacy business, while positive for total profit dollars, led to a 9 basis point decline in the underlying FIFO gross margin rate, a headwind that requires continuous cost offsets.
Despite accelerating growth of 16%, the e-commerce business is not yet profitable. A strategic review is underway, and achieving profitability in this segment remains a critical, unproven step for long-term value.
⚖️ Verdict: 🟢
Bullish. The consistent, multi-quarter acceleration in the core identical sales metric, coupled with tangible proof of cost discipline flowing to the bottom line, is a powerful combination. The decision to raise full-year guidance across the board demonstrates strong operational control and execution that appears to be more than offsetting known headwinds from consumer caution and business mix.
Key Themes
Disciplined Cost Control Funds the Flywheel
A key highlight of the quarter was the significant improvement in the operating expense rate, which, excluding the effect of the Specialty Pharmacy sale, decreased by 41 basis points. This demonstrates a renewed focus on productivity and efficiency under new leadership. These savings are being reinvested into strategic price reductions on over 3,500 items to improve customer value perception and drive volumes, while also contributing to profit growth. This cost-to-investment strategy is a core driver of the current momentum.
E-commerce Growth Accelerates as Delivery Takes the Lead
E-commerce continues to be a powerful growth engine, with sales accelerating to 16% in Q2, up from 15% in Q1. For the first time, delivery sales surpassed pickup sales, indicating a shift in consumer preference toward convenience. Kroger is well-positioned for this trend, leveraging its store network to offer delivery in under two hours from 97% of its locations. This asset-light approach is central to the company's strategic review aimed at forging a clear path to profitability for the segment.
Strong Performance in Health, Wellness, and Private Brands
Growth was led by strong results in Pharmacy and Fresh categories. The pharmacy business benefited from script growth and GLP-1 medications, while Fresh categories like meat and produce continue to outpace center-store sales. Concurrently, Kroger's 'Our Brands' private label portfolio once again outgrew national brands, improving margin mix and catering to value-conscious shoppers.
Cautious Consumer and Tougher Second-Half Comps
Management continues to highlight a cautious consumer, particularly in low and middle-income groups who are using more coupons and focusing on value. Discretionary categories remain soft. This backdrop is coupled with tougher year-over-year comparisons in the second half. The CFO explicitly stated this is factored into guidance, with Q3 ID sales expected to be 'slightly below the midpoint' of the new annual range, implying a sequential deceleration from Q2's +3.4%.
Gross Margin Rate Pressured by Pharmacy Mix
The strong growth in the Pharmacy business creates a mix headwind for gross margins. While driving significant profit dollars, its lower margin rate was the primary reason for a 9 basis point decline in the underlying FIFO gross margin rate this quarter. Management stated their goal is to remain 'margin neutral' for the full year, indicating this pressure requires constant offsetting from sourcing initiatives and cost controls.
Strategic Shift Towards New Store Growth
Management is signaling a greater emphasis on capital allocation towards higher-return projects, specifically new stores. The company is on track for 30 major store projects in 2025 and plans to accelerate this with a 30% increase in store openings in 2026. This focus on expanding the physical footprint in high-growth areas is seen as the primary driver of sustainable market share gains.
Other KPIs
Kroger ended the quarter with a net total debt to adjusted EBITDA ratio of 1.63x, significantly below its target range of 2.30x to 2.50x. This strong balance sheet provides ample flexibility for growth investments, like the planned acceleration of new stores, and continued capital returns to shareholders. The company expects to complete its remaining $2.5 billion open market share repurchase authorization by the end of the fiscal year.
The company remains committed to returning capital. In Q2, the quarterly dividend was increased by 9%, marking the 19th consecutive year of increases. Following the completion of the ongoing $5 billion Accelerated Share Repurchase (ASR) program in Q3, Kroger plans to execute its remaining $2.5 billion open market authorization by the end of FY25.
Guidance
Accelerating trend. The guidance range was raised from 2.25%-3.25%. The new midpoint of 3.05% reflects strong first-half momentum. However, this implies a deceleration in the second half of the year as the company faces tougher prior-year comparisons.
Stable to improving. The bottom end of the range was raised from $4.60, tightening the outlook and reflecting higher confidence in profitability for the year. This was driven by the strong sales performance and effective cost management.
Stable to improving. Similar to EPS, the lower end of the guidance was raised from $4.7 billion. This confirms that the top-line strength is expected to translate into bottom-line results for the full year.